Literature DB >> 32010406

Successful Treatment of Isotretinoin Induced Musculoskeletal Pain by Vitamin B12 and Folic Acid.

Amir Feily1.   

Abstract

BACKGROUND: Daily supplementation with vitamin B12 and folate, which are the cofactors of the enzymatic reactions involved in Hcy metabolism, can lower plasma levels of Hcy and prevent osteoporosis induced by retinoid. CASE
PRESENTATION: We reported six patients with nodulocystic acne who reported musculoskeletal pain after taking isotretinoin which successfully treated with daily supplementation of folic acid and B12.
CONCLUSION: We suggest our colleagues consider these supplements when a patient suffers from musculoskeletal pain following starting isotretinoin and continue the treatment as well. In the end, the authors concluded that robust trials with more patients are needed to establish the efficacy of Vit B12 and folic acid in the treatment of isotretinoin induced musculoskeletal pain. Copyright:
© 2019 Amir Feily.

Entities:  

Keywords:  Folic acid; Isotretinoine; Vit B12

Year:  2019        PMID: 32010406      PMCID: PMC6986527          DOI: 10.3889/oamjms.2019.799

Source DB:  PubMed          Journal:  Open Access Maced J Med Sci        ISSN: 1857-9655


Introduction

Acne vulgaris is a chronic inflammatory disease affecting the pilosebaceous unit in the skin. Isotretinoin is a vitamin A derivative is the most effective agent in the treatment of acne. A substantial amount of studies reports of adverse effects of isotretinoin on the skeletal system [1], [2], [3], [4], [5]. Namazi and Feily in 2010 suggested that retinoid-induced hyperhomocysteinemia may account for osteoclast overactivity, osteoporosis, and increased risk of bone fracture associated with retinoid use. As a hypothesis, they suggested Daily supplementation with vitamin B12 and folate, which are the cofactors of the enzymatic reactions involved in Hcy metabolism, can lower plasma levels of Hcy and prevent osteoporosis induced by retinoid [4], [5]. Accordingly, we reported six patients with nodulocystic acne who reported musculoskeletal pain after taking isotretinoin which successfully treated with daily supplementation of folic acid and B12. Six patients (Table 1) had previously been treated with isotretinoin reported musculoskeletal pain after starting isotretinoin for their nodulocystic acne. Three of them around 20 days, one of them one mouth and the other two patients after 45 days of taking isotretinoin reported the musculoskeletal pain. Four of them reported back pain and two reported leg pain. Two of the patients had the history of taking isotretinoin and musculoskeletal pain which caused them to discontinue the treatment. There was not any other rheumatologic or other past history for all of them. Routine labdates were normal too.
Table 1

Patients Treatment and Evolution

PatientSex / Age (yrs)Follow upArea of musculoskeletal painTime of the pain after starting isotretinoinHistory of pain after taking isotretinoinResponse to vitb12 and Folic acid
1F⁄ 188 monthsBackAround 20 days after starting isotretinoinNegativePositive
2F⁄ 216 monthsLegAround 20 days after starting isotretinoinNegativePositive
3F⁄ 248 monthsBackAround 45 days after starting isotretinoinPositivePositive
4M⁄ 206 monthsBackAround 30 days after starting isotretinoinNegativePositive
5F⁄ 298 monthsLegAround 20 days after starting isotretinoinPositivePositive
6F/226 monthsBackAround 20days after starting isotretinoinNegativePositive
Patients Treatment and Evolution In all patients, we started Folic Acid 1 mg daily and vitamin B12 injection every two weeks until more than 6 months follow up. After two weeks of treatment, the partial improvement was noted, and over the next week, further reduction in musculoskeletal pain was observed and After 6 weeks the symptoms completely disappeared, and all patients continued their treatment until 6 months. It has been shown that the amino acid homocysteine level is elevated in patients on isotretinoin treatment for acne, which may be due to the inhibition of cystathionine-beta-synthase by the drug and/or the drug-induced liver dysfunction [4], [5], [6]. Higher levels of Hcy have been linked to higher fracture rate in the elderly and have been noted as a new risk factor for osteoporosis. Also, hyperhomocysteinemia has some adverse effects on the extracellular bone matrix by damaging collagen crosslinking [4], [5]. Accordingly, we think Daily supplementation with vitamin B12 and folate, maybe by affecting on enzymatic reactions involved in Hcy metabolism, could lower their plasma levels of Hcy and musculoskeletal pain. We suggest our colleagues consider these supplements when a patient suffers from musculoskeletal pain following starting isotretinoin and continue the treatment as well. In the end, the authors concluded that robust trials with more patients are needed to establish the efficacy of Vit B12 and folic acid in the treatment of isotretinoin induced musculoskeletal pain.
  6 in total

1.  Hyperhomocysteinemia: can't it account for retinoid-induced fracture proneness?

Authors:  Mohammad Reza Namazi; Amir Feily
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 Mar-Apr       Impact factor: 2.545

Review 2.  Decrease of insulin growth factor-1 as a novel mechanism for anti-androgen effect of isotretinoin and its reported association with depression in some cases.

Authors:  Amir Feily; Mohammad R Namazi
Journal:  J Drugs Dermatol       Date:  2011-07       Impact factor: 2.114

3.  Palpebral involvement as a presenting and sole manifestation of discoid lupus erythematosus.

Authors:  Reza Yaghoobi; Amir Feily; Bahar Behrooz; Elena Yaghoobi; Shabnam Mokhtarzadeh
Journal:  ScientificWorldJournal       Date:  2010-11-04

4.  The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.

Authors:  Leyla Baykal Selçuk; Deniz Aksu Arıca; Hanife Baykal Şahin; Savas Yaylı; Sevgi Bahadır
Journal:  Cutan Ocul Toxicol       Date:  2016-11-16       Impact factor: 1.820

5.  13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands?

Authors:  Teresa Karlsson; Anders Vahlquist; Natalia Kedishvili; Hans Törmä
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

6.  Adjuvant Narrow Band UVB Improves the Efficacy of Oral Azithromycin for the Treatment of Moderate to Severe Inflammatory Facial Acne Vulgaris.

Authors:  Sima Rassai; Esmaeil Rafeie; Marigdalia K Ramirez-Fort; Amir Feily
Journal:  J Cutan Aesthet Surg       Date:  2014-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.